Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Rognoni

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 11, 2010
Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levelsValeria Ferrero, Fabrizio Tomai, Francesco Versaci, et al.
The Journal of Invasive Cardiology|July 5, 2014
Clinical and biomechanical behavior of a platinum-chromium stent platform in a large all-comer single-center population: insights from the Novara-PROMETEUS registryAlessandro Lupi, Italo Porto, Andrea Rognoni, et al.
European Heart Journal. Acute Cardiovascular Care|July 12, 2015
Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplastyAlessandro Lupi, Andrea Rognoni, Chiara Cavallino, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 16, 2014
Similar anti-inflammatory effects of intracoronary and intravenous abciximab during primary percutaneous coronary intervention: a randomized studyGioel Gabrio Secco, Mara Sansa, Andrea Rognoni, et al.
Journal of Clinical Medicine|February 15, 2022
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19Giulia Renda, Fabrizio Ricci, Enrico Guido Spinoni, et al.
Journal of Thrombosis and Thrombolysis|June 10, 2021
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19Marco G Mennuni, Roberta Rolla, Leonardo Grisafi, et al.
American Heart Journal|August 10, 2016
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trialCyril Camaro, Sander A J Damen, Marc A Brouwer, et al.
International Journal of Cardiology|August 17, 2013
Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patientsAlessandro Lupi, Andrea Rognoni, Gioel Gabrio Secco, et al.
International Journal of Cardiology|February 1, 2016
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study)Simone Biscaglia, Fabrizio Ugo, Alfonso Ielasi, et al.
International Journal of Cardiology|December 15, 2023
Achievement of target LDL-cholesterol level in patients with acute coronary syndrome undergoing percutaneous coronary intervention: The JET-LDL registryMarco Ferlini, Andrea Munafò, Ferdinando Varbella, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 11, 2010
Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levelsValeria Ferrero, Fabrizio Tomai, Francesco Versaci, et al.
The Journal of Invasive Cardiology|July 5, 2014
Clinical and biomechanical behavior of a platinum-chromium stent platform in a large all-comer single-center population: insights from the Novara-PROMETEUS registryAlessandro Lupi, Italo Porto, Andrea Rognoni, et al.
European Heart Journal. Acute Cardiovascular Care|July 12, 2015
Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplastyAlessandro Lupi, Andrea Rognoni, Chiara Cavallino, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 16, 2014
Similar anti-inflammatory effects of intracoronary and intravenous abciximab during primary percutaneous coronary intervention: a randomized studyGioel Gabrio Secco, Mara Sansa, Andrea Rognoni, et al.
Journal of Clinical Medicine|February 15, 2022
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19Giulia Renda, Fabrizio Ricci, Enrico Guido Spinoni, et al.
Journal of Thrombosis and Thrombolysis|June 10, 2021
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19Marco G Mennuni, Roberta Rolla, Leonardo Grisafi, et al.
American Heart Journal|August 10, 2016
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trialCyril Camaro, Sander A J Damen, Marc A Brouwer, et al.
International Journal of Cardiology|August 17, 2013
Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patientsAlessandro Lupi, Andrea Rognoni, Gioel Gabrio Secco, et al.
International Journal of Cardiology|February 1, 2016
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study)Simone Biscaglia, Fabrizio Ugo, Alfonso Ielasi, et al.
International Journal of Cardiology|December 15, 2023
Achievement of target LDL-cholesterol level in patients with acute coronary syndrome undergoing percutaneous coronary intervention: The JET-LDL registryMarco Ferlini, Andrea Munafò, Ferdinando Varbella, et al.
Pageof 13